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Abst rac t : The inhibitory effect of newly synthesized C- (anthranyl and biphenyl)-5-substituted-52r 
isoxazolines were characterized by IR, 'H NMR, l3C NMR and CHN analysis and evaluated for their 
antimicrobial activity against different strains. Such as Bacillus substilis, Escherichia coli, Pseudomonas 
fluorescens, Xanthomonas campestris pvs, Xanthomonas oryzae, Aspergillus niger, Aspergillus flavus, 
Fusarium oxvsporum, Trichoderma species and Fusarium monaliforme . Among the newly synthesized 
compounds, 6b III, 6b IV and 6b VI showed significant inhibitor activity. 
Introduction 
Antimicrobials reduce or completely block the growth and multiplication of bacteria. This has made them 
unique for the control of deadly infectious diseases caused by a variety of pathogens. They have 
transformed our ability to treat infectious diseases such as pneumonia, meningitis, tuberculosis, malaria 
and AIDS. The synthesis of 2-isoxazolines has recently received considerable attention in the search for 
the compounds with anti-inflammatory (1-2) and antifungal activity (3). Previous reports show that the 
compounds possessing isoxazole and isoxazoline ring systems show a variety of biological activities like 
insecticidal, antibacterial, antibiotic, antitumor, antifungal (4-6) and in some pharmaceutical agents such 
as GP1I b/Illa inhibitors (7) and human leukocyte elastase inhibitors (8). Nitrile oxides undergo (3+2) 
cycloaddition with olefins and acetylenes to provide isoxazolines and isoxazoles respectively (9). 1 , 3 — 
dipolar cycloaddition of a nitryl oxide to alkenes is a useful procedure for the construction of δ2-
isoxazoli.nes, which are versatile intermediates for the synthesis of a wide variety of natural products and 
are important pharmacophores in medicinal chemistry. As part of our continuing effort for the discovery 
of novel synthetic molecules, here in we report the synthesis of some 52-isoxazoline derivatives and their 
antimicrobial activity against Bacillus substilis, Escherichia coli, Pseudomonas fluorescens, 
Xanthomonas campestris pvs, Xanthomonas oryzae, Aspergillus niger, Aspergillus flavus, Fusarium 
oxvsporum, Trichoderma species and Fusarium monaliforme . 
Chemistry 
The synthesis of anthranyl and biphenyl substituted 52-isoxazolines has been carried out by using their 
respective aldoximes through 1,3-dipolar cycloaddition with the mono substituted alkenes and 
Choramine-T as an oxidant (10). The key intermediates anthraldoxime and biphenylaldoxime have been 
prepared by using hydroxylamine sulphate and sodium acetate from our reported method (3). Since nitryl 
oxides dimerize readily, they are usually generated in situ and trapped by dipolarophiles. Even though the 
chemical diversities on solid phase have attracted tremendous attention because of their potential 
application in rapid drug discovery (11), but it is very difficult to get pure products in good yields. So we 
stabilized the solution phase synthesis of isoxazolines via 1,3-dipolar cylcoaddition reactions by using 
different oxidants. 
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Results and Discussions 
Chemistry 
Previous and the present report on several derivatives of bio-applicable isoxazoli (di) nes synthesis 
involves the trapping or utilization of the in situ generated 1,3-dipolar species such as nitryl oxides or 
nitrones, which bearing bulky groups generated from aldoximes oxidation by using cheaper reagents. The 
cycloaddition with the alkenes gave exclusively 5-substituted isoxazolines consisting of high 
regioselectivity (Scheme-1). 
CHO CH=N-OH 
(ii) 
R 
3b(l - VI) 3a(l - VI) 
Reaction Condition 
6b(l - VI) 6a(l - VI) 
(i) (NH20H)H2S04 (ii) CAT/Ethanol 
NaOCOCH3 
Methanol 
Where R = I) -OOCCH3 
II) -COOC6H5 
III) -COOC2H5 
IV) -COO(CH2)3-CH3 
V) -COOCH3 
VI) -CH2OH 
Scheme-1 
All the compounds were purified through column chromatography by using n-hexane, ethyl 
acetate, chloroform and methanol as different solvent systems. The 'H NMR spectra at 4.6-4.70 (dd) and 
at 4.9 (t) clearly confirm the formation of the isoxazoline ring moiety as reported earlier 
(Table-1). 
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Table 1: Reaction condition and physical data of (?- isoxazolines. 
Heterocyclic Communications 
62-isoxazolines Solvent 
Reaction 
time (lirs) Rf Value 
Eluent used in 
separation Yield (%) 
3b-I 
3b-II 
3b-III 
3b-IV 
3b-V 
3b-VI 
6b-I 
6b-II 
6b-lII 
6b-IV 
6b-V 
6b-VI 
Ethanol 
Ethanol 
Ethanol 
Methanol 
Ethanol 
Ethanol 
Methanol 
Methanol 
Ethanol 
Methanol 
Methanol 
Methanol 
10 
10 
12 
12.5 
7.5 
14 
15 
9.5 
9.5 
11 
0.63 Benzene/Ehtylacetate 75 
9:1 
0.50 Benzene/Ehtylacetate 80 
9:1 
0.45 n-Hexane/Ehtylacetate 65 
8:2 
0.48 n-Hexane/Ehtylacetate 72 
8:2 
0.62 Benzene/Ehtylacetate 70 
9:1 
0.56 Benzene/Ehtylacetate 82 
9:1 
0.75 n-Hexane/Ehtylacetate 69 
8:2 
0.50 n-Hexane/Ehtylacetate 76 
8:2 
0.49 Benzene/Ehtylacetate 58 
9:1 
0.56 Benzene/Ehtylacetate 66 
9:1 
0.67 Benzene/Ehtylacetate 77 
9:1 
0.44 Benzene/Ehtylacetate 59 
9:1 
Biology 
In view of synthesizing new antimicrobials, we have synthesized Anthranyl 3b(I VI) and biphenyl 
' substituted 6b(I-VI) isoxazoline and evaluated for their antimicrobial activity by disk diffusion methods 
against different strains. Streptomycin, tetracycline and nystatin as positive controls. All tests were 
performed in duplicate and the results are the means of atleast three determinations. Our results reveals 
that the biphenyl substituted 2-isoxazolines, 6b III, 6b IV, 6b VI showed better activity when compared 
to standard and among anthranyl substituted 2-isoxazolines, 3b III, 3 b IV, 3b VIexhibi ted similar 
potency, comparable to standards against both fungal and bacterial strains tested (Table2 and Table-3). 
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Table-2 : Inhibitory Zone (diameter) mm of synthesized compounds against tested 
bacterial strains by disk diffusion method 
Compounds Inhibitory Zone (diameter) mm" 
Bacilhis-
-substilis 
Escherichia -
-coli 
Pseudomonas -
-fluorescens 
Xanthomonas -
-campestris pvs. 
Xanthomonas -
-oryzae 
3b I 19+0.8 22+0.98 28+1.2 16+0.7 17+0.8 
3b II 21+0.9 18±0.8 27+1.3 21±0.98 18+0.72 
3b III 10±0.4 11 ±0.45 18+0.8 13+0.5 12+0.5 
3b IV 11+0.42 12+0.5 17+0.7 12+0.42 10+0.42 
3b V 20+0.89 21+0.91 29+1.3 23+1.1 20+0.9 
3bVI 12±0.52 13±0.56 16+0.7 11 ±0.45 11 ±0.42 
6b I 17±0.75 16±0.7 21+0.9 14±0.6 15+0.7 
6 b l l 18+0.76 19+0.9 24+0.95 16±0.7 14±0.52 
6 b i l l 6±0.21 7+0.31 12+0.5 10±0.4 8±0.32 
6 b IV 7±0.3 9±0.4 10+0.4 8+0.32 9+0.41 
6b V 1910.89 18+0.8 23+1.1 19+0.8 18+0.81 
6b VI 8+0.32 11 ±0.41 13+0.6 9+0.4 8+0.3 
Streptomyci 12 ±0.5 14± 0.6 18+0.7 - -
η 
Tetracycline - - - 12±0.5 11+0.5 
Streptomycin sulphate (25 jig/disc); Tetracycline (25 ng/disc) were used as positive reference standard antibiotic 
discs, Synthesized compounds (25 ng/disc). 
" Values are means of three determinations, the ranges of which are less than 5% of the mean in all cases. 
Table-3 : Inhibitory Zone (diameter) mm of synthesized compounds against tested fungal strains by 
disk diffusion method. 
Inhibitory Zone (diameter) m m a 
Compound Aspergillus-
-niger 
Aspergillus -
-flavus 
Fusarium -
-oxysporum 
Trichoderma— 
species. 
Fusariitm-
-monaliforme 
3b I 14+0.6 15+0.65 17+0.8 19+0.81 16+0.71 
3b II 15+0.7 14±0.66 19+0.89 22+0.98 18+0.82 
3b III 8+0.3 10±0.47 13+0.53 14+0.64 11+0.43 
3b IV 10+0.41 9+0.41 13+0.51 15+0.67 10+0.45 
3b V 12+0.52 14+0.66 16+0.74 19+0.91 15+0.7 
3 b VI 9+0.4 11 ±0.49 14±0.6 16+0.72 12+0.51 
6b I 20+0.9 18±0.82 22±0.9 19+0.87 17+0.8 
6 b l l 18+0.82 17±0.72 19±0.85 17+0.71 18+0.81 
6 b i l l 5+0.2 5+0.21 9+0.4 8+0.34 7±0.3 
6 b IV 6+0.25 7±0.3 11 ±0.43 10+0.43 9±0.4 
6 b V 2 2 + 0 . 9 8 17+0.76 19+0.8 18+0.8 16+0.7 
6 b VI 7±0.28 6+0.24 10+0.4 9±0.4 8±0.32 
Nystatin 8±0.32 10+0.4 14+0.61 16+0.7 12±0.52 
Nystatin (25 ^ig/disc) was used as positive reference standard antibiotic discs, Synthesized compounds (25 ng/disc) 
"Values are means of three determinations, the ranges of which are less than 5% of the mean in all cases. 
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Conclusions 
In conclusion, herein we report the synthesis of anthranyl and biphenyl substituted 52-isoxazolines and 
their efficacy as antimicrobials. Compounds 6b III, 6b IV, 6b VI showed potent inhibition and also 3b 
III, 3b IV, 3b VI showed significant inhibition against standard tested 
Experimental 
Biology 
Bacteria and fungal species used were obtained from microbiology department, University of Mysore, 
India. Namely, Bacillus substilis, Escherichia coli, Pseudomonas fluorescens, Xanthomonas campestris 
pvs, Xanthomonas oryzae, Aspergillus niger, Aspergillus flavus, Fusarium oxysporum, Trichoderma 
species and Fusarium monaliforme. The bacterial strains were maintained on LB agar medium and the 
filamentous fungi were maintained on Potato dextrose agar (PDA) medium at 28°C. The disk diffusion 
method (12) was used to determine antimicrobial activity of synthesized compounds. Paper discs with 
only DMSO were used as negative controls. 
The bacteria were grown in LB broth, centrifuged at 10,000 rpm for 5 mins, pellet was dissolved in 
double distilled and used to inoculate the plates. For the filamentous fungi, the inoculum was prepared 
with the spores derived from 5 to 15 days culture on PDA medium. The mycelia were covered with 10 
niL of distilled water and the conidia were scraped using sterile pipette. The spores were recovered after 
filtration on sterile absorbent cotton and were resuspended in sterile distilled water. The cell density of 
each inoculum was adjusted with hemocytometer in order to obtain a final concentration of approximately 
•1 6 
10 CFU/mLand 10 CFU/mL for the bacteria and filamentous fungi respectively. 
Nystatin (Himedia) was used as positive control for fungi and streptomycin and tetracycline for 
bacteria. Each disk contained 25ng of standard drugs and synthesized compounds. Plates were first kept 
at 4°C for at least 2 hours to allow the diffusion of chemicals, and then incubated at 28°C. Inhibition 
zones were measured after 24 hours of incubation for bacteria and after 48 hours of incubation for fungi. 
The Nutrient liquid medium and Potato dextrose liquid medium were used as test media. 
Chemistry 
Hie melting points were determined on SELACO-650 hot stage apparatus and are uncorrected. IR (nujol) 
spectra were measured on Shimadzu 8300 IR spectrophotometer, 'H NMR were recorded on Shimadzu 
AMX 400-Bruker, 400 MHz spectrometer by using CDCI3 as solvent and TMS as an internal standard 
(chemical shift in δ ppm). Elemental analyses were obtained on a Vario-EL instrument. TLC was 
conducted on 0.25 mm silica gel plates (60F254, Merck) and Column by silica gel BDH 60-120 meshes. 
All extracted solvents were dried overNa2S04 , followed by evaporation in vacuo. 
Synthesis of anthracene-9-caibaIdehyde oxime (2) 
A solution of 9-anthranyl carbaldehyde (lg, 4.848 mmol) in methanol (15ml) was added to a mixture of 
hydroxylamine sulfate (1.193g, 7.268 mmol) and sodium acetate (1.193g, 14.54 mmol). The reaction 
mass was refluxed for 4-5 hrs till the reaction completes. Evaporated the solvent under vacuo and added 
40ml of demineralised water, cooled to 5-8° C and filtered at the same temperature to obtain the 
crystalline solid (0.987g). m.p = 159-161°C, IR (nujol) cm"1 1675 (CH=N), 3240 (OH). 
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Synthesis of biphenyl-4-carbaldeliyde oxiine (5) 
The compound 5 was obtained by using 4-biphenyl carbaldehyde ( lg , 5.4878 m mol), hydroxylamine 
sulfate (1.351g, 8.234 mmol) and sodium acetate (1.35g, 16.46 mmol) with the above protocol, m.p = 
142-147 °C, IR (nujol) ein1 1689 (CH=N), 3235 (OH). 
General procedure for the synthesis of novel 82-isoxazolines 3b(I - VI) and 6b(I - VI) 
A solution of aldoxime 2 (2 equivalent) in ethanol or methanol was added to a solution of alkene (1 
equivalent), Chloramine-T (1.5 equivalent) and refluxed for 12-14 hrs to complete the reaction, which 
was monitored by thin layer chromatography. After completion of the reaction, the solvent was 
evaporated under vacuo. Eight volumes of demineralised water was added to the residue and extracted the 
crude with 4 volumes of methylendichloride thrice. The organic layer was washed with 5% NaHC0 3 
solution. Using appropriate mixture solvent systems as eluent in silica gel column separated the pure 
products. 
Synthesis of acetic acid-3-anthracene-9-yl-4, 5-dihydro-isoxazole-5yl-ester 3b-I. 
It was obtained from 9-anthralaldoxime 2 (0.25g, 1.1298 mmol) vinyl acetate (0.097g, 1.1298 mmol) and 
Chloramine-T (0.35 g, 1.242 mmol). IR (nujol) cm"1 1750 (C=0), 1670 ( O N ) , 840 (N-O); *H NMR 
(CDC13, 400 MHz) δ: 1.89 (s, 3H, -COCH3), 5.2-5.28 (dd, 2H, J=6.2[Hz] ,C4H), 6.60 (t, 1 H, J=8[Hz] 
,C5H), 7.61-7.63 (s, 1H, Ar-H), 7.4 (t, 2H, Ar-H), 7.89-7.94 (s, 2H, Ar-H), 8.29 (s, 2H, Ar-H), 8.05-8.15 
(d, 2H, Ar-H); l3C: 125.41 (4C), 126.401 (3C), 128.55 (4C), 128.97 (4C), 130.769, 133.4 (4C), 155.61 
(2C), 168.0; Anal. CHN: calcd 74.75, 4.918, 4.590, found 74.15, 4.5321, 4.290 
Synthesis of 3-anthracene-9-yl-4, 5-dihydro-isoxazole-5-carboxylic acid phenyl ester 3b-II 
It was obtained from 9-anthralaldoxime 2 (0.25g, 1.1298 mmol) vinyl benzoate (0.1674 g, 1.1298 mmol) 
and Chloramine-T (0.477 g, 1.6947 mmol). IR (nujol) cm"1 1725 ( O O ) , 1654 ( O N ) , 845 (N-O); 'H 
NMR (CDCI3, 400 MHz) δ: 7.2-7.4 (m, 3H, Ar-H), 7.0-7.15 (d, 2H, Ar-H), 4.9 (t, 1H, C5H), 4.3 (dd, 1H, 
.7=7[Hz], C4H); 13C: 125.41 (4C), 128.55 (4C), 120.9 (2C), 133.4 (4C), 126.401 (3C), 152.1, 168.2, 70.5, 
25.1, 130.769, 165.2; Anal. CHN: calcd 78.474, 4.632, 3.8147, found 78.17, 4.531, 3.67. 
Synthesis of 3-anthracene-9-yl-4, 5-dihydro-isoxazole-5-carboxylic acid ethyl ester 3b-III 
It was obtained from 9-anthralaldoxime 2 (0.25g, 1.1298 mmol) ethyl acrylate (0.113 g, 1.1298 mmol) 
and Chloramine - T (0.477g, 1.6933 mmol). IR (nujol) cm"1 1745 ( O O ) , 1680 ( ( O N ) , 780 (N-O); 'H 
NMR (CDCI3, 400 MHz) δ: 1.29 (t, 3H, -CH3), 4.05-4.18 (q, 2H, -OCH2-), 3.9 (dd, 1H, J= 8[Hz], C5H), 
3.25 (d, 2H, C4H), 7.39 (t, 2H, Ar-H), 7.91 (s, 2H, Ar-H), 8.32 (s, 2H, Ar-H), 8.1-8.18 (d, 2H, Ar-H); I3C: 
123.12 (2C), 129.24 (3C), 124.38 (3C), 134.21 (4C), 121.07 (2C), 14.2, 24.4, 58.9, 71.4, 17.3, 165.4; 
Anal. CHN: calcd 75.235, 5.329, 4.388, found 75.135, 5,410, 4.40. 
Synthesis of 3-anthracene-9-yl-4, 5-dihydro-isoxazole-5-carboxyIic acid butyl ester 3b-IV 
It was obtained from 9-anthralaldoxime 2 (0.25g, 1.1298 mmol) butyl acrylate (0.144 g, 1.1298 mmol) 
and Chloramine-T (0.477g, 1.6933 mmol). IR (nujol) cm"1 1710 ( O O ) , 1645 ( O N ) , 820 (N-O); 'H 
NMR (CDCI3, 400 MHz) δ: 0.92 (t, 3H, -CH3), 1.25 (m, 2H, -CH2-CH3), 1.68 (q, 2H, -CH2-), 3.95-4.05 
(t, 2H, -OCH2), 3.9-4.12 (t, 1H, J=6.4[Hz], C5H), 3.15 (dd, 1H, y=8[Hz], C4H), 7.75 (t, 2H, Ar-H), 7.94-
8.01 (s, 2H, Ar-H), 8.15-8.32 (s, 2H, Ar-H), 8.25 (d, 2H, Ar-H); 13C: 126.4 (2C), 127.9 (3C), 123.65 (3C), 
131.5 (4C), 120.54 (2C), 13.5, 20.1, 24.5, 31.8, 65.4, 71.51, 171, 165.4; Anal. CHN: calcd 76.080, 6.05, 
4.034, found 75.83,6.12,4.1 . 
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Synthesis of 3-antliracene-9-yI-4, 5-dihydro-isoxazole-5-carboxyIic acid methyl ester 3b-V 
It was obtained from 9-anthraIaldoxime 2 (0.25g, 1.1298 mmol) methyl acrylate (0.097 g, 1.1298 mmol) 
and Chloramine-T (0.35g, 1.242 mmol). IR (nujol) cm"1 1735 (C=0) , 1615 (C=N), 805 (N-O); 'H NMR 
(CDCIj, 400 MHz) δ: 3.5 (s, 3H, -OCH3), 3.1- 3.22 (dd, 2H, J=7.4[Hz], C4H), 3.8-3.85 (t, 1H, CSH), 7.3 
(t, 2H, Ar-H), 7.7 (s, 2H, Ar-H), 8.34-8.38 (s, 2H, Ar-H), 8.7-7.0 (d, 2H, Ar-H), 7.45 (d, 1H, Ar-Η); l3C: 
23.2, 51.5, 72.1, 126.2 (3C), 125.9 (3C), 134.51 (4C), 133, 129, 127.4 (2C); Anal. CHN: calcd 74.75, 
4.918, 4.290, found 74.35, 4.812, 4.40. 
Synthesis of 3-anthracene-9-yI-4, 5-dihydro-isoxazoIe-5-yI-methanol 3b-VI 
It was obtained from 9-anthralaldoxime 2 (0.25g, 1.1298 mmol) ally! alcohol (0.13 lg, 2.25 mmol) and 
Chloramine-T (0.477g, 1.6933 mmol). IR (nujol) cm"1 3240 (OH), 1630 (C=N), 835 (N-O); 'H NMR 
(CDC13, 400 MHz) δ: 2.78 (dd, 2H, J= 10[Hz], C4H), 3.2 (m, 1H, C4H), 3.7 (d, 2H, -CH2OH), 7.42 (t, 2H, 
Ar-H), 7.65 (s, 2H, Ar-H), 8.28-8.34 (s, 2H, Ar-H), 7.85 (d, 2H, Ar-H), 7.5 (d, 1H, Ar-H); ,3C: 25.9, 67.8, 
68.4, 123.2 (3C), 125.7 (3C), 127.4 (2C), 131.3 (4C), 133.5, 165.1; Anal. CHN: calcd 77.978, 5415, 
5.054, found 78.02, 5215,5.154. 
Synthesis of acetic acid 3-biphenyl-4-yl-4, 5-dihydro-isoxazole-5-yl ester 6b-I 
It was obtained from 4-biphenyl aldoxime 5 (0.25g, 1.2676 mmol), vinyl acetate (0.1091 g, 1.2676 mmol) 
and Chloramine-T (0.535g, 1.9014 mmol). IR (nujol) cm"1 1745 (C=0) , 1620 (C=N), 785 (N-O); 'H 
NMR (CDCI3, 400 MHz) δ: 2.15 (s, 3H, COCH3), 3.05 - 3.10 (dd, 2H, J=8[Hz], C4H), 5.05 (t, 1H, C5H), 
7.45 - 7.49 (m, 4H, Ar-H), 7.65 (d, 2H, Ar-H), 7.35 (t, 2H, Ar-H), 7.15 (t, 1H, Ar-H); 13C: 16.5, 25.6, 
89.1, 128.1 (4C), 126.5 (4C), 125.2 (2C), 126.1, 131.5, 161, 170.4; Anal. CHN: calcd 72.59,5 .338,4 .982, 
found 71.99, 5.130, 4.673. 
Synthesis of 3-biphenyl-4-yl-4, 5-dihydro-isoxazole-5-carboxyIic acid phenyl ester 6b-II 
It was obtained from 4-biphenyl aldoxime 5 (0.25g, 1.2676 mmol), vinyl benzoate (0.1878 g, 1.2676 
mmol) and Chloramine-T (0.535g, 1.9014 mmol). IR (nujol) cm"1 1710 (C=0) , 1620 (C=N), 775 (N-O); 
'H NMR (CDC13, 400 MHz) δ: 3.6-3.8 (dd, 2H, J= 4.1 [Hz], C4H), 4.05-4.15 (t, 1H, C5H), 7.05 (d, 3H, 
Ar-H), 7.25 (m, 3H, Ar-H), 7.56-7.66 (m, 4H, Ar-H), 7.75-7.81 (d, 2H, Ar-H), 7.15 (t, 1H, Ar-H); l3C: 
24.5, 70.4, 167.2, 152.7, 122 (2C), 129.6 (2C), 130.5 (4C), 126.1 (4C), 135, 139, 125.41, 129, 161.3; 
Anal. CHN: calcd 76.968, 4.956, 4.081, found 76.988, 4.732, 4.180. 
Synthesis of 3-biphenyl-4-yl-4, 5-dihydro-isoxazole-5-carboxyIic acid ethyl ester 6b-III 
It was obtained from 4-biphenyl aldoxime 5 (0.25g, 1.2676 mmol), ethyl acrylate (0.126 g, 1.2676 mmol) 
and Chloramine-T (0.535g, 1.9014 mmol). IR (nujol) cm"1 1740 (C=0) , 1654 (C=N), 785 (N-O); 'H 
NMR (CDCI3, 400 MHz) δ: 1.2 (t, 3H, CH3), 4.05 (q, 2H, OCH2), 3.1-3.15 (dd, 1H, J= 8.4[Hz]) 7.05-7.15 
(t, 1H, Ar-H), 7.4-7.65 (m, 4H, Ar-H), 7.85 (d, 2H, Ar-H); 13C: 15, 56.5, 24.1, 70.4, 128.81 (4C), 126.8 
(4C), 129, 137, 140.8, 130, 163, 173.1; Anal. CHN: calcd 73.220, 4.956, 4.081, found 73.100, 5.601, 
4.652. 
Synthesis of 3-biphenyl-4-yl-4, 5-dihydro-isoxazole-5-carboxyIic acid butyl ester 6b-IV 
It was obtained from 4-biphenyl aldoxime 5 (0.25g, 1.2676 mmol), butyl acrylate (0.162 g, 1.2676 mmol) 
and Chloramine-T (0.535g, 1.9014 mmol). IR (nujol) cm"1 1745 ( C O ) , 1620 (C=N), 765 (N-O); 'H 
NMR (CDCI3, 400 MHz) δ: 0.89 (t, 3H, CH3), 1.14 (m, 2H, CH2), 1.34 (q, 2H, CH2), 3.85-3.95 (t, 2H, -
OCH2), 3.12-3.2 (dd, 2H, J= 6.8[Hz], C4H), 4.12-4.19 (t, 1H, CSH), 7.32-7.4 (m, 4H, Ar-H), 7.1 (d, 2H, 
Ar-H), 7.01-7.05 (t, 1 H, Ar-H); l3C: 12.3, 1.5, 25.1, 32.4, 65.9, 70.4, 128.24 (4C), 130.4 (4C), 128.3, 139, 
135, 168.1, 173; Anal. CHN: calcd 74.303, 6.5015, 4.334, found 74.102, 6.301, 4.323. 
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Synthesis of 3-biphenyl-4-yl-4, 5-dihydro-isoxazole-5-carboxyIic acid methyl ester 6b-V 
It was obtained from 4-biphenyl aldoxime 5 (0.25g, 1.2676 mmol), methyl aciylate (0.1091 g, 1.2676 
mmol) and Chloramine-T (0.535g, 1.9014 mmol). 1R (nujol) cm"1 1735 (C=0), 1615 (C=N), 815 (N-O); 
Ϊ1 MMR (CDCI3, 400 MHz) δ: 1.2 (t, 3H, CH3), 4.05 (q, 2H, OCH2), 3.1-3.15 (dd, 1H, y=8.6[Hz]), 7.05-
7.15 (t, 1H, Ar-H), 7.4- 7.65 (m, 4H, Ar-H), 7.85 (d, 2H, Ar-M); 13C: 15, 56.5, 24.1, 70.4, 128.81 (4C), 
126.8 (4C), 129, 137, 140.8, 130, 163, 173.1; Anal. CHN: calcd 72.59, 5.338, 4.982, found 72.623, 5.128, 
4.763. 
Synthesis of 3-biphenyl-4-yl-4, 5-diIiydro-isoxazole-5-yl-methanol 6b-VI 
It was obtained from 4-biphenyl aldoxime 5 (0.25g, 1.2676 mmol), allyl alcohol (0.073 g, 1.2676 mmol) 
and Chloramine-T (0.535g, 1.9014 mmol). IR (nujol) cm"1 3100 (OH), 1654 (C=N), 785 (N-O); 'H NMR 
(CDCI3, 400 MHz) δ: 0.89 (t, 3H, CH3), 1.14 (m, 2H, -CH2), 1.34 (q, 2H, -CH r ) , 3.85-3.95 (t, 2H, -
OCI I2), 3.12-3.2 (dd, 2H, J= 6.8[Hz], C4H), 4.12-4.19 (t, 1H, CSH), 7.32-7.48 (m, 4H, Ar-H), 7.1 (d, 2H, 
Ar-H), 7.01-7.05 (t, 1H, Ar-H); l3C: 12.3, 18.5, 25.1, 32.4, 65.9, 70.4, 128.24 (4C), 128, 139, 135, 168.1, 
173; Anal. CHN: calcd 75.889, 5.928, 5.533, found 75.752, 5.839, 5.232. 
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